1507930-57-5
Chemical Structure
Gap19
- CAS No.: 1507930-57-5
- Formula:C55H96N14O13
- Molecular Weight:1161.44
IUPAC Name: L-lysyl-L-glutaminyl-L-isoleucyl-L-glutamyl-L-isoleucyl-L-lysyl-L-lysyl-L-phenylalanyl-L-lysine
InChIKey: IEAKEKFIXUZWEH-PKMKMBMKSA-N
SMILES: NCCCC[C@H](N)C(N[C@@H](CCC(N)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(O)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@H](C(O)=O)CCCCN)=O)CC1=CC=CC=C1)=O)=O)=O)=O)=O)=O)=O
Biological Activity: Gap19, a peptide derived from nine amino acids of the Cx43 cytoplasmic loop (CL), is a potent and selective connexin 43 (Cx43) hemichannel blocker. Gap19 inhibits hemichannels caused by preventing intramolecular interactions of the C-terminus (CT) with the CL. Gap19 is not blocking GJ channels or Cx40/pannexin-1 hemichannels. Gap19 has protective effects against myocardial[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Gap19 | 99.84% | Gap19, a peptide derived from nine amino acids of the Cx43 cytoplasmic loop (CL), is a potent and selective connexin 43 (Cx43) hemichannel blocker. Gap19 inhibits hemichannels caused by preventing intramolecular interactions of the C-terminus (CT) with the CL. Gap19 is not blocking GJ channels or Cx40/pannexin-1 hemichannels. Gap19 has protective effects against myocardial. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.82
HY-P5410OVA-Q4 Peptide -
Similarity Score 0.80
HY-P10506CMX-8933 -
Similarity Score 0.80
HY-P2319OVA-E1 peptide -
Similarity Score 0.78
HY-P10179ARF6 (2-13) -
Similarity Score 0.78
HY-P1489OVA Peptide(257-264) -
Similarity Score 0.77
HY-P2319AOVA-E1 peptide TFA -
Similarity Score 0.77
HY-P2444Platelet factor 4 (59-70) -
Similarity Score 0.77
HY-P1489AOVA Peptide(257-264) TFA -
Similarity Score 0.76
HY-P10246Hemoglobin (64-76) -
Explore the MedChemAI to find more analogs
References
- [1]. Boengler K, et al. Connexin 43 impacts on mitochondrial potassium uptake. Front Pharmacol. 2013 Jun 6;4:73. [Content Brief]
- [2]. Wang N, et al. Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury. Basic Res Cardiol. 2013 Jan;108(1):309. [Content Brief]
